AIGH Capital Management’s Vaccinex, Inc. Common Stock VCNX Stock Holding History

AIGH Capital Management’s Portfolio VCNX Stock Details VCNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-108,958	Closed	-$424K	–	49
2024 Q2	$424K	Buy	108,958 +50,593	+87%	+$305K	0.13%	38
2024 Q1	$432K	Buy	58,365 +3	+0%	+$26	0.13%	41
2023 Q4	$543K	Sell	58,362 -19,508	-25%	-$231K	0.21%	34
2023 Q3	$1.23M	Buy	77,870 +71,429	+1,109%	+$3.63M	0.58%	39
2023 Q2	$472K	Buy	6,441 +1,909	+42%	+$159K	0.19%	46
2023 Q1	$380K	Sell	4,532 -7,143	-61%	-$785K	0.14%	49
2022 Q4	$1.66M	Buy	11,675 +1,762	+18%	+$218K	0.55%	36
2022 Q3	$1.03M	Hold	9,913	–	–	0.32%	37
2022 Q2	$2.25M	Hold	9,913	–	–	0.59%	26
2022 Q1	$2.63M	Buy	+9,913	New	+$2.74M	0.64%	25

Other funds holding VCNX

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

AIGH Capital Management's VCNX Position: Q3 2024 in Review

AIGH Capital Management sold out of Vaccinex, Inc. Common Stock (VCNX) in Q3 2024, closing a stake of 108,958 shares — an estimated $424K sold.

AIGH Capital Management first reported a position in VCNX in Q1 2022 and held it in 10 quarters. The position peaked at $2.63M in Q1 2022. 12 funds tracked by Wall St. Rank hold VCNX as of Q3 2024.

AIGH Capital Management reported no remaining Vaccinex, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
AIGH Capital Management sold 108,958 Vaccinex, Inc. Common Stock shares in Q3 2024, an estimated $424K.
AIGH Capital Management first reported a position in Vaccinex, Inc. Common Stock in Q1 2022 and held it in 10 quarters.
AIGH Capital Management's Vaccinex, Inc. Common Stock position peaked at $2.63M in Q1 2022.
12 funds tracked by Wall St. Rank held Vaccinex, Inc. Common Stock as of Q3 2024.

Based on AIGH Capital Management's 13F filing for Q3 2024, filed 13 Nov 2024.